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efforts need to be done to receive appropriate information on time,
maybe to establish also sentinel active surveillance systems to
detect serious adverse events
http://dx.doi.org/10.1016/j.ijid.2016.11.361
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Purpose: In spite of the use of pneumococcal conjugate vaccines
(PCVs), there are some reports of increasing incidence of compli-
cated pneumonia, accompanied by signiﬁcant pleural effusion or
empyema, caused by Streptococcus pneumoniae. Some serotypes
seem to be more frequently associated to this clinical presentation,
such as serotypes 1, 3, 5, 7F and 19A. We aimed to characterize the
pneumococcal population causing complicated pneumonia and to
evaluate the roleofmolecular techniques in theenhanceddetection
of this important pathogen in pleural ﬂuid samples.
Methods & Materials: Pleural effusion or empyema samples
from pediatric patients, recovered in Portugal between 2010 and
2015 were included. When traditional culture methods revealed S.
pneumoniae these were serotyped. In culture negative cases, sam-
ples were analyzed by conventional and RT-PCR for S. pneumoniae
detection and serotyping.
Results: 109 out of 152 cases of complicated pneumonia were
conﬁrmed to be due to S. pneumoniae. The majority of cases
(n=92) were diagnosed by molecular methods. The most frequent
serotypes were serotypes 3, 1 and 19A together accounting for
62% (n=68) of the isolates. Some of the patients included in this
study had infections due to vaccinal serotypes, in spite of being age
appropriately vaccinated.
Conclusion: The high prevalence of the additional serotypes
included in PCV13 is probably due to a higher propensity of these
serotypes to cause complicated pneumonia, although the longtime
use of PCV7may have contributed to the decline of PCV7 serotypes.
Thepersistenceof somePCV13serotypes in spiteof vaccination isof
concern. Ongoing surveillance studies are essential to understand
the dynamics of the pneumococcal population after the inclusion
of PCV13 in the National Immunization plan in Portugal.
http://dx.doi.org/10.1016/j.ijid.2016.11.362
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Purpose: Bacterial meningitis (BM) is characterized by severe
clinical manifestations, and signiﬁcant rate of residual effects. It is
continue to be a common cause of morbidity and mortality world-
wide In Kazakhstan, according to statistics Consumer Protection
Committee (CPC) BM recorded in all regions of the country but this
epidemiological data was never been analyzed linked with clinical
information.
Study’s aim: To determine morbidity characteristics of BM in
children <14 years in various regions of Kazakhstan during 2014-
2015.
Methods&Materials:Dataobtained fromCPCofKazakhstan for
BMwas analyze for the country and by region in children <14 years.
The introduction of Hib vaccine in 2008 into the national vaccina-
tion schedule and during 2010 - 2015 the 13-valent pneumococcal
conjugated vaccine (PCV13) was gradually introduced in the coun-
try. Applying themethodsofmodernbiomedical statistics:Analysis
of extensive performance analysis and intensive indicators. Statis-
tical analysis was performed using Statistics 9.0.
Results: N. meningitidis was the most common bacteria, 70%
of all cases, followed by pneumococcus, 10-15%,. The highest inci-
dence of BM in 2015, determined in Almaty 24.81%, in Astana
24.05%, but in comparison with the year 2014 these ﬁgures
decreased to half. In the other regions of the country incidence
rates, of disease was absent in 2014, Akmola (0.6%), West Kazakh-
stan (0.67%), Kyzylorda (1.27%), Mangystau (0.52%), and North
Kazakhstan (1.73%). During 2015 a signiﬁcant increase of incidence
of BM was observed compared to 2014 year in Almaty region, from
0.75% to 6.18%.
Conclusion: In the Kazakhstan Republic among children <14
year in 2015 compared to the year 2014 established decrease of BM
from 5.52% to 4.49% for 100,000 population, while in other regions
there is a consistent trend of increased morbidity.
http://dx.doi.org/10.1016/j.ijid.2016.11.363
